Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
RAR-related orphan receptor gamma | 7 | 0 | 0 | 7 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
heat shock protein beta-1 | 5 | 0 | 0 | 5 |
importin subunit beta-1 isoform 1 | 3 | 0 | 0 | 3 |
DNA polymerase beta | 2 | 0 | 0 | 2 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
snurportin-1 | 3 | 0 | 0 | 3 |
DNA polymerase iota isoform a (long) | 5 | 0 | 0 | 5 |
geminin | 9 | 0 | 0 | 9 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
muscleblind-like protein 1 isoform 1 | 3 | 0 | 0 | 3 |
lamin isoform A-delta10 | 5 | 0 | 0 | 5 |
Bile salt export pump | 0 | 11 | 0 | 11 |
14 kDa phosphohistidine phosphatase | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 3 | 0 | 0 | 3 |
Chain A, Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Chain A, Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Chain A, Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Chain A, Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Smad3 | 2 | 0 | 0 | 2 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
cytochrome P450 2D6 | 4 | 0 | 0 | 4 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
lysosomal alpha-glucosidase preproprotein | 4 | 0 | 0 | 4 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Amyloid-beta precursor protein | 0 | 2 | 0 | 2 |
Procathepsin L | 0 | 0 | 1 | 1 |
Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
Cytochrome P450 2C8 | 0 | 0 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 4 | 1 | 5 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
Spike glycoprotein | 3 | 0 | 1 | 4 |
Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 3 | 0 | 0 | 3 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 4 | 0 | 0 | 4 |
DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
pregnane X receptor | 2 | 0 | 0 | 2 |
GLI family zinc finger 3 | 11 | 0 | 0 | 11 |
AR protein | 10 | 0 | 0 | 10 |
estrogen receptor 2 (ER beta) | 5 | 0 | 0 | 5 |
nuclear receptor subfamily 1, group I, member 3 | 5 | 0 | 0 | 5 |
progesterone receptor | 5 | 0 | 0 | 5 |
retinoic acid nuclear receptor alpha variant 1 | 9 | 0 | 0 | 9 |
retinoid X nuclear receptor alpha | 7 | 0 | 0 | 7 |
estrogen-related nuclear receptor alpha | 11 | 0 | 0 | 11 |
farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
pregnane X nuclear receptor | 7 | 0 | 0 | 7 |
estrogen nuclear receptor alpha | 13 | 0 | 0 | 13 |
peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
peroxisome proliferator activated receptor gamma | 6 | 0 | 0 | 6 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 7 | 0 | 0 | 7 |
aryl hydrocarbon receptor | 4 | 0 | 0 | 4 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 5 | 0 | 0 | 5 |
thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
activating transcription factor 6 | 4 | 0 | 0 | 4 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 7 | 0 | 0 | 7 |
thyroid hormone receptor beta isoform 2 | 7 | 0 | 0 | 7 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 9 | 0 | 0 | 9 |
Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
Cellular tumor antigen p53 | 6 | 0 | 0 | 6 |
Glutamate receptor 2 | 3 | 0 | 0 | 3 |
Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
acetylcholinesterase | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
SMAD family member 2 | 2 | 0 | 0 | 2 |
USP1 protein, partial | 3 | 0 | 0 | 3 |
SMAD family member 3 | 2 | 0 | 0 | 2 |
TDP1 protein | 7 | 0 | 0 | 7 |
Microtubule-associated protein tau | 3 | 0 | 0 | 3 |
caspase 7, apoptosis-related cysteine protease | 3 | 0 | 0 | 3 |
glucocorticoid receptor [Homo sapiens] | 7 | 0 | 0 | 7 |
67.9K protein | 1 | 0 | 0 | 1 |
caspase-3 | 3 | 0 | 0 | 3 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
thyrotropin-releasing hormone receptor | 3 | 0 | 0 | 3 |
vitamin D3 receptor isoform VDRA | 4 | 0 | 0 | 4 |
mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 2 | 0 | 0 | 2 |
Caspase-2 | 0 | 0 | 1 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 3 | 0 | 0 | 3 |
Ataxin-2 | 3 | 0 | 0 | 3 |
interleukin 8 | 2 | 0 | 0 | 2 |
aldehyde dehydrogenase 1 family, member A1 | 6 | 0 | 0 | 6 |
EWS/FLI fusion protein | 3 | 0 | 0 | 3 |
G | 3 | 0 | 0 | 3 |
streptokinase A precursor | 0 | 0 | 4 | 4 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 2 |
ATP-binding cassette sub-family C member 3 | 0 | 6 | 0 | 6 |
Multidrug resistance-associated protein 4 | 0 | 6 | 0 | 6 |
Interferon beta | 5 | 0 | 0 | 5 |
HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
30S ribosomal protein S6 | 0 | 4 | 1 | 5 |
30S ribosomal protein S7 | 0 | 4 | 1 | 5 |
50S ribosomal protein L15 | 0 | 4 | 1 | 5 |
Cytochrome P450 3A4 | 0 | 4 | 0 | 4 |
50S ribosomal protein L10 | 0 | 4 | 1 | 5 |
50S ribosomal protein L11 | 0 | 4 | 1 | 5 |
50S ribosomal protein L7/L12 | 0 | 4 | 1 | 5 |
50S ribosomal protein L19 | 0 | 4 | 1 | 5 |
50S ribosomal protein L1 | 0 | 4 | 1 | 5 |
50S ribosomal protein L20 | 0 | 4 | 1 | 5 |
50S ribosomal protein L27 | 0 | 4 | 1 | 5 |
50S ribosomal protein L28 | 0 | 4 | 1 | 5 |
50S ribosomal protein L29 | 0 | 4 | 1 | 5 |
50S ribosomal protein L31 | 0 | 4 | 1 | 5 |
50S ribosomal protein L31 type B | 0 | 4 | 1 | 5 |
50S ribosomal protein L32 | 0 | 4 | 1 | 5 |
50S ribosomal protein L33 | 0 | 4 | 1 | 5 |
50S ribosomal protein L34 | 0 | 4 | 1 | 5 |
50S ribosomal protein L35 | 0 | 4 | 1 | 5 |
50S ribosomal protein L36 | 0 | 4 | 1 | 5 |
30S ribosomal protein S10 | 0 | 4 | 1 | 5 |
30S ribosomal protein S11 | 0 | 4 | 1 | 5 |
30S ribosomal protein S12 | 0 | 4 | 1 | 5 |
30S ribosomal protein S13 | 0 | 4 | 1 | 5 |
30S ribosomal protein S16 | 0 | 4 | 1 | 5 |
30S ribosomal protein S18 | 0 | 4 | 1 | 5 |
30S ribosomal protein S19 | 0 | 4 | 1 | 5 |
30S ribosomal protein S20 | 0 | 4 | 1 | 5 |
30S ribosomal protein S2 | 0 | 4 | 1 | 5 |
30S ribosomal protein S3 | 0 | 4 | 1 | 5 |
30S ribosomal protein S4 | 0 | 4 | 1 | 5 |
30S ribosomal protein S5 | 0 | 4 | 1 | 5 |
30S ribosomal protein S8 | 0 | 4 | 1 | 5 |
30S ribosomal protein S9 | 0 | 4 | 1 | 5 |
50S ribosomal protein L13 | 0 | 4 | 1 | 5 |
50S ribosomal protein L14 | 0 | 4 | 1 | 5 |
50S ribosomal protein L16 | 0 | 4 | 1 | 5 |
50S ribosomal protein L23 | 0 | 4 | 1 | 5 |
30S ribosomal protein S15 | 0 | 4 | 1 | 5 |
50S ribosomal protein L17 | 0 | 4 | 1 | 5 |
50S ribosomal protein L21 | 0 | 4 | 1 | 5 |
50S ribosomal protein L30 | 0 | 4 | 1 | 5 |
50S ribosomal protein L6 | 0 | 4 | 1 | 5 |
30S ribosomal protein S14 | 0 | 4 | 1 | 5 |
30S ribosomal protein S17 | 0 | 4 | 1 | 5 |
30S ribosomal protein S1 | 0 | 4 | 1 | 5 |
50S ribosomal protein L18 | 0 | 4 | 1 | 5 |
50S ribosomal protein L2 | 0 | 4 | 1 | 5 |
50S ribosomal protein L3 | 0 | 4 | 1 | 5 |
50S ribosomal protein L24 | 0 | 4 | 1 | 5 |
50S ribosomal protein L4 | 0 | 4 | 1 | 5 |
50S ribosomal protein L22 | 0 | 4 | 1 | 5 |
50S ribosomal protein L5 | 0 | 4 | 1 | 5 |
30S ribosomal protein S21 | 0 | 4 | 1 | 5 |
50S ribosomal protein L25 | 0 | 4 | 1 | 5 |
50S ribosomal protein L36 2 | 0 | 4 | 1 | 5 |
Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
Methionine--tRNA ligase, mitochondrial | 0 | 0 | 1 | 1 |
cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 2 | 0 | 2 |
Protein-arginine deiminase type-4 | 0 | 6 | 0 | 6 |
Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
Motilin receptor | 0 | 0 | 1 | 1 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
low molecular weight phosphotyrosine protein phosphatase isoform c | 0 | 1 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
Motilin receptor | 0 | 1 | 1 | 2 |
Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
Albumin | 0 | 0 | 1 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Chitinase B | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Low molecular weight phosphotyrosine protein phosphatase | 0 | 1 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 3 | 0 | 3 |
Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
10 kDa chaperonin | 0 | 2 | 0 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 5 | 0 | 5 |
Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
PPM1D protein | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 4 | 0 | 0 | 4 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
IDH1 | 4 | 0 | 0 | 4 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 2 | 0 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Glucocorticoid receptor | 0 | 4 | 1 | 5 |
Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
glp-1 receptor, partial | 4 | 0 | 0 | 4 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 3 | 0 | 0 | 3 |
Cholesteryl ester transfer protein | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 3 | 0 | 0 | 3 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 3 | 0 | 0 | 1 | 1 |
Nicotinamidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 0 | 1 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 2 | 1 | 3 |
D-aspartate oxidase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 1 | 1 | 2 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
thioredoxin reductase | 3 | 0 | 0 | 3 |
WRN | 1 | 0 | 0 | 1 |
phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
GLS protein | 2 | 0 | 0 | 2 |
Valosin-containing protein | 0 | 1 | 0 | 1 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 4 | 0 | 0 | 4 |
Histone H2A.x | 4 | 0 | 0 | 4 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
chromobox protein homolog 1 | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase 1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase OXA-10 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Beta-lactamase TEM | 0 | 1 | 0 | 2 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Efflux transporter | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Class D beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-b-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase IMP-1 | 0 | 0 | 0 | 1 |
BlaVIM-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 1 |
Protein arginine N-methyltransferase 5 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Protein tyrosine phosphatase type IVA 3 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Coagulation factor X | 0 | 1 | 0 | 1 |
Plasminogen | 0 | 1 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
Protein S100-B | 0 | 1 | 1 | 2 |
Glyceraldehyde-3-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
Protein S100-B | 0 | 0 | 1 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Trypsin-1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Acrosin | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Amiloride-sensitive amine oxidase [copper-containing] | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Diamine acetyltransferase 1 | 0 | 1 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Protein tyrosine phosphatase type IVA 2 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
Protein tyrosine phosphatase type IVA 1 | 0 | 1 | 0 | 1 |
Aurora kinase B | 0 | 1 | 0 | 1 |
Protein arginine N-methyltransferase 1 | 0 | 1 | 0 | 1 |
Suppressor of tumorigenicity 14 protein | 0 | 1 | 0 | 1 |
GALC protein | 1 | 0 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
Vpr | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Luciferase | 1 | 0 | 0 | 1 |
Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, MUSCLE FATTY ACID BINDING PROTEIN | 0 | 0 | 1 | 1 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, adipocyte | 0 | 0 | 1 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor alpha | 0 | 0 | 1 | 1 |
Bile salt export pump | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 3 |
Chain A, Prostatic Acid Phosphatase | 0 | 1 | 0 | 1 |
90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 2 |
tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Neutrophil collagenase | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-synuclein | 1 | 1 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Collagenase 3 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Chain A, Repressor | 0 | 0 | 1 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
PINK1 | 1 | 0 | 0 | 1 |
polyprotein | 1 | 0 | 0 | 1 |
Parkin | 1 | 0 | 0 | 1 |
3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
twin arginine protein translocation system - TatA protein | 0 | 0 | 0 | 2 |
Transthyretin | 0 | 1 | 1 | 2 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
Endoplasmic reticulum chaperone BiP | 0 | 1 | 0 | 1 |
Carbonyl reductase [NADPH] 1 | 0 | 2 | 0 | 2 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | 0 | 2 | 0 | 2 |
Enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
Enoyl-acyl-carrier protein reductase | 0 | 2 | 0 | 2 |
Enoyl-ACP reductase II | 0 | 1 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
cytochrome P450 3A4 isoform 1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 1 | 0 | 0 | 1 |
GABA theta subunit | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |